PACAP expression and distribution in human breast cancer and healthy tissue.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Letters

• Publication date

  2004-03-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CANLET.2003.10.008PMID 15036651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression and distribution of pituitary adenylate cyclase-activating peptide in human prostate and prostate cancer tissues.

  2002cited by this paper
• On the birth of breast cancer.

  2001cited by this paper
• Similarities of prostate and breast cancer: Evolution, diet, and estrogens.

  2001cited by this paper
• Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study

  2000cited by this paper
• Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications.

  2000cited by this paper
• The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily.

  2000cited by this paper
• Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

  2000cited by this paper
• Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.

  2000cited by this paper
• Tumour marker measurements in the diagnosis and monitoring of breast cancer.

  2000cited by this paper
• THE ORIGIN AND FUNCTION OF THE PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)/GLUCAGON SUPERFAMILY

  2000cited by this paper
• Pituitary adenylate cyclase activating polypeptide (PACAP) is present in human and cat gastric glands☆

  1999cited by this paper
• Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides.

  1999cited by this paper
• Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat mammary gland

  1999cited by this paper
• Testis-specific prohormone convertase PC4 processes the precursor of pituitary adenylate cyclase-activating polypeptide (PACAP).

  1998cited by this paper
• Prohormones: their clinical relevance.

  1998cited by this paper
• Immunohistochemical demonstration of the intracellular localization of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat testis using the stamp preparation.

  1998cited by this paper
• New directions in breast cancer research 1

  1997cited by this paper
• Vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) in prostate carcinoma.

  1997cited by this paper
• Distribution and origin of peptide-containing nerve fibres in the rat and human mammary gland.

  1996cited by this paper
• Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Its Receptors: Neuroendocrine and Endocrine Interaction

  1995cited by this paper
• The lifetime risk of developing breast cancer.

  1993cited by this paper
• Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene.

  1992cited by this paper
• Mammalian cytoplasmic actins are the products of at least two genes and differ in primary structure in at least 25 identified positions from skeletal muscle actins.

  1978cited by this paper
• Hormone receptors: their role in predicting prognosis and response to endocrine therapy.

  1978cited by this paper

• The effect of PDLIM7 on cell proliferation, migration, and drug sensitivity in clear cell renal cell carcinoma

  2025cites this paper
• Investigation of PACAP38 and PAC1 Receptor Expression in Human Retinoblastoma and the Effect of PACAP38 Administration on Human Y-79 Retinoblastoma Cells

  2024cites this paper
• Dedifferentiated Schwann cells promote perineural invasion mediated by the PACAP paracrine signalling in cervical cancer

  2023cites this paper
• Multimodal Role of PACAP in Glioblastoma

  2021cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service

  2019cites this paper
• Signaling pathways activated by PACAP in MCF-7 breast cancer cells.

  2018cites this paper
• Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas

  2018cites this paper
• ADCYAP1 (adenylate cyclase activating polypeptide 1 (pituitary))

  2017cites this paper
• Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer Patients

  2017cites this paper
• Examination of PACAP During Lactation

  2016cites this paper
• PACAP and Cancer

  2016cites this paper
• Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16

  2015cites this paper
• Influence of Terminal Differentiation and PACAP on the Cytokine, Chemokine, and Growth Factor Secretion of Mammary Epithelial Cells

  2013cites this paper
• Plasticity of neuropeptidergic neoplasm cells in the primary and metastatic Merkel cell carcinoma.

  2013cites this paper
• Characteristic of galaninergic components of the enteric nervous system in the cancer invasion of human large intestine.

  2012cites this paper
• Changes in PACAP Immunoreactivity in Human Milk and Presence of PAC1 Receptor in Mammary Gland during Lactation

  2012cites this paper
• Concentration of vasoactive intestinal polypeptide, neuropeptide Y and calcitonin gene related peptide in neoplastic tissue of the human large intestine

  2011cites this paper
• The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.

  2010cites this paper
• Expression of Trophic Peptides and Their Receptors in Chromaffin Cells and Pheochromocytoma

  2010cites this paper
• Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling.

  2009cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

  2009cites this paper
• Molecular Characterization of Lung Dysplasia Induced by c-Raf-1

  2009cites this paper
• Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.

  2007cites this paper
• Breast Cancer VPAC1 Receptors

  2006cites this paper
• VIP and PACAP as Autocrine Growth Factors in Breast and Lung Cancer

  2006cites this paper
• Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue

  2005cites this paper
• I. PERSONAL I.1 PERSONAL INVESTIGADOR

  2004cites this paper
• CATEDRÁTICOS DE UNIVERSIDAD Y EMÉRITOS

  2004cites this paper